Phibro Animal Health (PAHC) grants 2,716 RSUs to director Jonathan Bendheim

Rhea-AI Filing Summary

BENDHEIM Jonathan reported acquisition or exercise transactions in this Form 4 filing.

PHIBRO ANIMAL HEALTH CORP reported that director Jonathan Bendheim received a grant of 2,716 restricted stock units (RSUs), each representing a contingent right to receive one share of Class A Common Stock. Following this award, his directly held Class A Common Stock position is 5,984 shares.

The RSUs are scheduled to vest in substantially equal installments on each of the first three anniversaries of August 1, 2026, subject to his continued employment through each applicable vesting date.

Insider Trade Summary

Net Buyer: 2,716 shares

Net Buy 1 txn

Insider BENDHEIM Jonathan

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Class A Common Stock F1, F2	2,716	$0.00	$0.00

Holdings After Transaction: Class A Common Stock — 5,984 shares (Direct)

Footnotes (2)

1. F1. The reported securities represent restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of Class A Common Stock.
2. F2. The RSUs vest in substantially equal installments on each of the first three anniversaries of August 1, 2026, subject to the Reporting Person's continued employment through the applicable vesting date.

Key Figures

RSUs granted: 2,716 units Shares held after award: 5,984 shares Vesting schedule: Three substantially equal installments

3 metrics

RSUs granted 2,716 units Restricted stock units awarded to Jonathan Bendheim representing Class A Common Stock

Shares held after award 5,984 shares Class A Common Stock directly held by Jonathan Bendheim following the transaction

Vesting schedule Three substantially equal installments RSUs vest on each of the first three anniversaries of August 1, 2026, subject to continued employment

Key Terms

restricted stock units, Class A Common Stock, contingent right to receive

3 terms

restricted stock units financial

"The reported securities represent restricted stock units ("RSUs"), each of which represents a contingent right"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Class A Common Stock financial

"each of which represents a contingent right to receive one share of Class A Common Stock"

Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.

contingent right to receive financial

"RSUs, each of which represents a contingent right to receive one share of Class A Common Stock"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/10/2026 - 04:17 PM Accepted by SEC EDGAR 08/10/2026 - 04:17 PM Learn about SEC filing dates

FAQ

What transaction did Jonathan Bendheim report on this Form 4 for PAHC?

Jonathan Bendheim reported an award of 2,716 restricted stock units (RSUs), each convertible into one share of Class A Common Stock, as part of his equity compensation at Phibro Animal Health Corp.

How many PAHC shares does Jonathan Bendheim hold after this RSU grant?

After the reported RSU grant, Jonathan Bendheim directly holds 5,984 shares of Phibro Animal Health Corp Class A Common Stock, as disclosed in the Form 4 filing for this transaction.

How do the new RSUs for PAHC’s Jonathan Bendheim vest?

The 2,716 RSUs granted to Jonathan Bendheim vest in substantially equal installments on each of the first three anniversaries of August 1, 2026, assuming his continued employment through each vesting date.

What does each RSU granted to Jonathan Bendheim by PAHC represent?

Each restricted stock unit granted to Jonathan Bendheim represents a contingent right to receive one share of Phibro Animal Health Corp Class A Common Stock, subject to satisfaction of the vesting conditions.

Was the PAHC Form 4 transaction a market purchase or sale of shares?

The PAHC Form 4 reports a grant or award acquisition of 2,716 RSUs to Jonathan Bendheim, not a market purchase or sale, with no cash price per share shown for the award.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

BENDHEIM Jonathan

(Last) (First) (Middle)

300 FRANK W. BURR BLVD., STE 21

(Street)

TEANECK NEW JERSEY 07666

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
PHIBRO ANIMAL HEALTH CORP [ PAHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/06/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock(1)	08/06/2026		A		2,716(2)	A	$0	5,984	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The reported securities represent restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of Class A Common Stock.

2. The RSUs vest in substantially equal installments on each of the first three anniversaries of August 1, 2026, subject to the Reporting Person's continued employment through the applicable vesting date.

	/s/ Judith Weinstein, as Attorney-in-Fact for Jonathan Bendheim	08/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)